Bladder Cancer,Genitourinary Cancer Serial ctDNA Testing: Prognostic Tool in High-Risk MIBC Apr 18, 2024
Bladder Cancer,Genitourinary Cancer Antitumor Activity of S095018 + Sym021 in Biliary Tract Cancer Apr 17, 2024
Bladder Cancer,Genitourinary Cancer Nivolumab in Adjuvant Urothelial Carcinoma: Survival Benefit Apr 16, 2024
Bladder Cancer,Genitourinary Cancer Examination of Psoriasis & Bladder Cancer: MR Analysis Apr 03, 2024
Bladder Cancer,Genitourinary Cancer uMRD Predicts NIMBC Recurrence & Nadofaragene Response Apr 01, 2024
Bladder Cancer,Genitourinary Cancer Neoadjuvant Nivolumab + Ipilimumab in UTUC: Updated Results Mar 28, 2024
Bladder Cancer,Genitourinary Cancer Gemcitabine/Cisplatin ± Berzosertib in mUC: Extended Follow-up Mar 26, 2024
